NCT00308750 2021-05-13First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)Eli Lilly and CompanyPhase 2 Completed218 enrolled 17 charts
NCT00533429 2021-05-13Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With ChemotherapyEli Lilly and CompanyPhase 2 Completed40 enrolled 17 charts
NCT00415363 2020-11-05Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation TherapyEli Lilly and CompanyPhase 2 Completed109 enrolled 18 charts
NCT00530621 2020-07-01Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung CancerEli Lilly and CompanyPhase 2 Completed160 enrolled 18 charts